Clinical TRIal to EvaLUate Cardiovascular OutcoMes IN PAtients Treated with the Tricuspid ValvE Repair System Pivotal (TRILUMINATE Pivotal)
TRILUMINATE Pivotal: Study of Cardiovascular Outcomes Treated with the TriClip Device in Patients with Severe Tricuspid Regurgitation
Sponsor: Abbott Vascular, Inc.
Enrolling: Male and Female Patients
IRB Number: AAAS4612
U.S. Govt. ID: NCT03904147
Contact: Kate Dalton: 347-514-3366 / keb2114@cumc.columbia.edu
Additional Study Information: The goal is to evaluate the safety and effectiveness of the TriClip device in patients with severe Tricuspid Regurgitation (TR) and are deemed greater risk for mortality with tricuspid valve surgery.
This study is closed
Investigator
Susheel Kodali, MD
Do You Qualify?
Are you 18 years of age or older? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Kate Dalton
keb2114@cumc.columbia.edu
347-514-3366
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE